|
| Press Releases |
|
 |
|
| Friday, September 23, 2022 |
|
|
Malaysian Genomics Grows Presence in Thailand |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
| Wednesday, September 21, 2022 |
|
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
| Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
| Monday, August 29, 2022 |
|
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
| Thursday, August 18, 2022 |
|
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
| Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
| Wednesday, July 20, 2022 |
|
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
| UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
| Friday, July 15, 2022 |
|
|
Malaysian Genomics Appoints New Chairman |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
| Wednesday, July 13, 2022 |
|
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
| Friday, July 8, 2022 |
|
|
Malaysian Genomics Proposes Private Placement |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
| Wednesday, July 6, 2022 |
|
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
MiniMax官宣向AI平台型公司邁進 ARR超1.5億美金夯實底盤
Mar 3, 2026 18:25 HKT/SGT
|
|
|
MiniMax官宣向AI平台型公司迈进 ARR超1.5亿美金夯实底盘
Mar 3, 2026 18:20 HKT/SGT
|
|
|
Lincotrade Unveils Freehold Residential Project, The Shang Residence, in Kuala Lumpur, Malaysia
Mar 3, 2026 16:22: JST
|
|
|
Exito Media Concepts Announces the 32nd Edition of the Manufacturing IT Summit - Thailand 2026
Mar 3, 2026 16:18: JST
|
|
|
Concord New Energy Signs MOU with Bain Capital-Backed Bridge Data Centre
Mar 3, 2026 15:27 HKT/SGT
|
|
|
華領醫藥宣佈多格列艾汀在中國香港獲批上市
Mar 3, 2026 12:51 HKT/SGT
|
|
|
华领医药宣布多格列艾汀在中国香港获批上市
Mar 3, 2026 12:37 HKT/SGT
|
|
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Mar 3, 2026 12:14 HKT/SGT
|
|
|
The Tomorrow Company Launches With a Bold Mandate to Build the Infrastructure Layer of the AI-Native Financial Era.
Mar 3, 2026 11:34: JST
|
|
|
愛康醫療(1789.HK)獲納入中證港股通機器人主題指數 凸顯機器人領域投資潛力
Mar 3, 2026 10:45 HKT/SGT
|
|
|
爱康医疗(1789.HK)获纳入中证港股通机器人主题指数 凸显机器人领域投资潜力
Mar 3, 2026 10:36 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES, 소결 금(Au) 접합기술 ‘AuRoFUSE(TM) Preforms’ 전사 기술 확립
Mar 3, 2026 10:00 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES 建立了燒結金(Au)接合技術「AuRoFUSE(TM) Preforms」的轉印技術
Mar 3, 2026 10:00 HKT/SGT
|
|
|
協合新能源與貝恩資本旗下Bridge Data Centres簽署諒解備忘錄
Mar 3, 2026 09:03 HKT/SGT
|
|
|
协合新能源与贝恩资本旗下Bridge Data Centres签署谅解备忘录
Mar 3, 2026 09:03 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
